Ensituximab (NEO-102, NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer[1][2].
Molecular Weight:
(142.82 kDa)
Purity:
99.93
CAS Number:
[1092658-06-4]
Target:
Mucin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted